1/17/2025 at 5:41:44 PM
Very glad to see this, it's worth noting that the compounded semiglutide pricing (think generic, although it's more complicated than that) has been plummeting ever since it was introduced onto the market. We've seen some pretty incredible results and I really hope they get cheap enough to be prescribed more widely.by some_random
1/17/2025 at 5:44:38 PM
It is worth noting that Compounded Semaglutide sold in the US is still more expensive than branded Semaglutide sold in other markets, where national price negotiations occur. For example, it can be under $100/month in several European nations.The US just has no mechanism to control prices. There isn't really competition for specific drugs.
by Someone1234
1/17/2025 at 7:27:44 PM
I think it is critical to differentiate price controls and purchasing controls.Most other markets with state insurance have purchasing controls. That is to say, if the price is too high, the government doesn't buy it.
Very few places have price controls e.g. "products cant be sold for more than X".
The US government is the outlier in that it situationally states it will pay the price no matter the cost.
Reasonable government policy needs to start with putting a price on human life (QALY), and purchasing goods and services that come in under that price. This is how it works in other state insurance systems.
by s1artibartfast
1/17/2025 at 8:16:58 PM
We aren't other state insurance systems, though.Instead, we have a divided and fractured jigsaw and heavy lobbying to keep it that way.
by simfree
1/17/2025 at 8:22:27 PM
Correct. You have identified a problemby s1artibartfast
1/17/2025 at 6:31:58 PM
The research peptide sites are about the only reasonable places to buy this stuffby chriscappuccio
1/17/2025 at 7:48:11 PM
Nonsetrile compounding, like you'd do from the peptide sites is only safe for immediate use, and semaglutide is not that way. You mix up a vial and use it for a month or so.Can you do it? Sure. Are you going to get an infection from it? Probably not. Is it riskier than having a compounding pharmacy doing it the right way? Absolutely, and in a meaningful amount of risk. The type of infections you get from contaminated injections are not something you want to deal with
by malfist
1/17/2025 at 9:16:17 PM
Haven't done it myself but there is a robust DIY community for GLP-1 drugs. No idea if anyone's gotten hurt yet or if it's been pretty okay so far.by spondylosaurus
1/17/2025 at 7:00:21 PM
[dead]by gnkyfrg
1/17/2025 at 6:44:20 PM
I’ve seen these comparisons a lot, but how is it determined that the actual quality of a name brand medicine is the same in the two different markets…?i.e. The price difference could be reflecting a real qualitative difference such as being produced in different facilities, slightly less pure ingredients, less stringent QC, etc…
by MichaelZuo
1/17/2025 at 7:02:32 PM
It feels very conspiratorial to suggest multinational pharmaceutical companies are creating low quality versions of their own branded drugs in Europe.We know that these drugs cost roughly $10/dose to produce, and most of that is the auto-injector pens. Hardly seems worth ruining their reputation and getting punished be regulators to save a few dollars on something with a 600-6000% markup.
by Someone1234
1/17/2025 at 7:05:28 PM
> We know that these drugs cost roughly $10/dose to produce…Can you link the source?
If it really is a 600% to 6000% markup then it does seem unlikely they would try to save a few dollars.
by MichaelZuo
1/17/2025 at 7:31:19 PM
yes, most of the costs are A) development and B) relatively fixed costs of maintaining the manufacturing staff and infrastructure.The marginal cost of an additional batch is relatively small in comparison.
by s1artibartfast
1/17/2025 at 9:08:40 PM
Developing a cheaper to produce product, even if that was done off-book and you could keep it secret, would need some level of different production methods (different ingredients, different machines or something which makes it cheaper) and some amount of testing which just selling the original product doesn't require.by AdamJacobMuller
1/17/2025 at 7:16:44 PM
https://www.cnbc.com/2024/03/27/novo-nordisk-ozempic-can-be-...by Someone1234
1/17/2025 at 7:42:34 PM
I think these calculations are wildly optimistic. As far as I can tell, they basically ignore the cost of development, labor, quality assurance, and regulatory.It is like estimating the cost of a rocket based on the price of metal.
by s1artibartfast
1/17/2025 at 8:00:12 PM
I think you've lost sight of what the discussion was about.The person above was claiming they were using substandard versions of their medication in non-US markets where the retail cost is lower. I was pointing out that the manufacturing cost is so low, that doesn't make sense.
Your point now has nothing to do with the discussion being had.
by Someone1234
1/17/2025 at 8:12:16 PM
I made a sibling comment agreeing with that point and expanding on why.However, bad data is bad data. If I said the moon creates waves because it is made of cheese, I think it is completely legitimate to point out out that it is in fact not made of cheese.
by s1artibartfast